# Phase 4 Study of Sto M Tab. in Acute or Chronic Gastritis

> **NCT07631065** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Mather's Pharm. Co., Ltd.** · enrollment: 470 (estimated)

## Conditions studied

- Gastritis
- Acute Gastritis
- Chronic Gastritis

## Interventions

- **DRUG:** Stillen Tab.
- **DRUG:** Sto M Tab.

## Key facts

- **NCT ID:** NCT07631065
- **Lead sponsor:** Mather's Pharm. Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06
- **Primary completion:** 2028-02
- **Final completion:** 2028-02
- **Target enrollment:** 470 (ESTIMATED)
- **Last updated:** 2026-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07631065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07631065, "Phase 4 Study of Sto M Tab. in Acute or Chronic Gastritis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07631065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*